Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women, according to BreastCancer.org.
They estimate that 30-percent of women diagnosed with cancer in 2017 was breast cancer. As of March, there are 3.1 million women living in the U.S. who have a history of breast cancer. This includes both women currently being treated and those who have finished their treatment of the deadly disease.
The numbers are scary but are actually getting better. Twenty years ago, the rate at which both women were being diagnosed and the mortality rate was much worse.
Many people believe that thanks to progressive research over the last 20 years has identified several potential causes of breast cancer and women began heeding the warnings.
But the disease still claims the lives of 40,000 women each year.
Thankfully, a team in Canada recently made the realization that there is a potential cure for breast cancer in the very near future.
A research team from Ottawa University believe they have discovered a potential treatment for triple negative breast cancer, considered the gravest form of the disease, through a combination of immunotherapy and an oncolytic virus.
Dr. Marie-Claude Bourgeois-Daigneault, a postdoctoral fellow in Dr. John Bell’s research lab, is the lead author of the groundbreaking study. Dr. Bell is considered one of the foremost experts in immunotherapy on the planet.
“It was absolutely amazing to see that we could cure cancer in most of our mice — even in models that are normally resistant to immunotherapy,” Dr. Bourgeois-Daigneault said.